The strategic $745M transaction opens new opportunities for Astrana in Orange County, California, where it has limited ...

The focus will be on immunology and cell engineering, with the goal of creating new cancer and autoimmune disease treatments.

Upon closing, the acquisition of RCA is expected to be approximately $0.35 accretive, net of estimated financing costs, to ...